Prospective Cohort Study: Whether or Not Patients Benefit From Participation Itself in Randomized-controlled Trials 2
Not Applicable
- Conditions
- Breast Cancer
- Registration Number
- JPRN-UMIN000021099
- Lead Sponsor
- SELECT BC-CONFIRM executive committee
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 44
Inclusion Criteria
Not provided
Exclusion Criteria
(i) Overexpression of HER2(Her2/neu, Erb B2), or the results of fluorescence in situ hybridization are positive. (ii) A past history of hypersensitivity to the protocoltreatment drugs or their solvents. (iii) The presence of other active cancers
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method